Article
Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations.
Pharmacogenetics and genomics - 1 Jan 2010
Azzato Elizabeth M, Chen Renee A, Wacholder Sholom, Chanock Stephen J, Klebanoff Mark A, Caporaso Neil E
Abstract excerpt
OBJECTIVES: The teratogenic effects of the anti-epileptic drug phenytoin have been linked to genetic differences in phenytoin disposition. The goal of this study was to assess the effect of maternal genotype of functional polymorphisms in two genes involved in phenytoin metabolism, CYP2C9 (R144C,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
